The PRISM Parkinson's Research Study

1540 Sunday Drive, Cary NC

Description

You Can Make a Difference and Help Accelerate Breakthroughs in Parkinson’s Disease Research. The PRISM Parkinson’s Research Study is now enrolling patients with early-stage Parkinson’s disease. About the PRISM Parkinson’s Research Study: The PRISM Parkinson's Research Study is evaluating an investigational drug to determine if it might slow down the progression of Parkinson’s disease (PD). Patients who enroll in this study will receive the study drug weekly over a period of 36 weeks. Study Criteria To participate in this study, patients must: • Be 30 to 80 years old • Have early-stage Parkinson’s disease • Not be on any current treatments for PD Other criteria for eligibility apply. Study participants receive study-related medical exams and study drug at no cost. Compensation for time and travel may be available. To see if you prequalify for the PRISM Parkinson's Research Study, call or visit PrismPDStudy.com.